SecurityBBRG / Bravo Brio Restaurant Group, Inc. (10567B109)
Institutional Owners58 (13 N-Q Owners)
Institutional Shares7,845,318 - 51.29% (ex. N-Q)
Common Shares Outstanding15,295,015 shares (as of 2017-12-31)
Institutional Value$ 369,657,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) has 58 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7,845,318 shares. Largest shareholders include Aristotle Capital Boston, LLC, Jackson Valley Fund Lp, Phr Holdings, Llc, BlackRock Inc., Eagle Boston Investment Management Inc, Philotimo Fund, LP, Dimensional Fund Advisors Lp, Synovus Financial Corp, Vanguard Group Inc, and Rice Hall James & Associates, Llc.

Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-09 13F-HR Bank of New York Mellon Corp 43,174 43,324 0.35 98 108 10.20
2018-02-28 N-Q Ishares Trust (see advisory)
2018-04-04 13F-HR First Financial Bank, N.A. - Trust Division 37,420 41,160 9.99 94 165 75.53
2018-02-13 13F-HR OXFORD ASSET MANAGEMENT 98,392 87,920 -10.64 231 222 -3.90
2018-02-26 N-Q Blackrock Funds (see advisory)
2017-12-14 13F-HR/A-1 PARAMETRIC PORTFOLIO ASSOCIATES LLC 10,722 0 -100.00 55 0 -100.00
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 346 919 165.61 1 2 100.00
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-02-12 13F-HR DIMENSIONAL FUND ADVISORS LP 492,021 486,702 -1.08 1,119 1,217 8.76
2017-11-22 N-Q Bridgeway Funds Inc (see advisory)
2018-01-09 SC 13G/A BlackRock Inc. 817,330 756,730 -7.41
2018-02-08 13F-HR SEI INVESTMENTS CO 53,709 70,415 31.10 122 176 44.26
2018-02-14 13F-HR MENTA CAPITAL LLC 24,427 24,427 0.00 56 61 8.93
2017-11-14 13F-HR Connor, Clark & Lunn Investment Management Ltd. 102,812 0 -100.00 473 0 -100.00
2017-10-23 N-Q Blackrock Series, Inc. (see advisory)
2018-01-13 SC 13G Jackson Valley Fund Lp 1,000,000
2017-11-14 13F-HR D. E. Shaw & Co., Inc. 222,152 0 -100.00 1,022 0 -100.00
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2018-02-12 13F-HR BRANDES INVESTMENT PARTNERS, LP 30,339 0 -100.00 69 0 -100.00
2018-02-13 13F-HR Cove Street Capital, LLC 200,000 195,200 -2.40 455 488 7.25
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2017-11-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 17,396 0 -100.00 80 0 -100.00
2018-01-05 13F-HR ADDISON CLARK MANAGEMENT, L.L.C. 128,945 0 -100.00 293 0 -100.00
2018-02-14 13F-HR UBS Group AG 0 3,317 0 8
2018-02-12 13F-HR Spark Investment Management LLC 56,900 33,000 -42.00 129 82 -36.43
2017-10-24 13F-HR FIRST TRUST ADVISORS LP 11,226 0 -100.00 52 0 -100.00
2018-02-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 14,000 14,000 0.00 31 35 12.90
2017-11-14 13F-HR GOLDMAN SACHS GROUP INC 65,330 0 -100.00 301 0 -100.00
2018-04-04 SC 13D/A Phr Holdings, Llc 832,916 762,916 -8.40
2017-11-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 800 0 -100.00 4 0 -100.00
2017-11-14 13F-HR A.R.T. Advisors, LLC 13,120 0 -100.00 60 0 -100.00
2018-02-14 13F-HR MORGAN STANLEY 72,194 64,482 -10.68 164 161 -1.83
2018-01-11 13F-HR WINSLOW ASSET MANAGEMENT INC 61,079 52,979 -13.26 139 132 -5.04
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 199,388 0 -100.00 498 0 -100.00
2018-02-14 13F-HR Invesco Ltd. 80,354 81,502 1.43 183 204 11.48
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 82,910 82,487 -0.51 189 206 8.99
2018-02-09 13F-HR EAGLE ASSET MANAGEMENT INC 149,000 0 -100.00 350 0 -100.00
2018-02-13 13F-HR JP Morgan Chase & Co 800 867 8.38 2 2 0.00
2018-02-14 SC 13G/A Aristotle Capital Boston, LLC 1,050,145
2018-02-01 13F-HR ALGERT GLOBAL LLC 130,860 136,678 4.45 298 342 14.77
2018-02-13 13F-HR WEBER ALAN W 25,000 25,000 0.00 450 66 -85.33
2018-02-14 13F-HR TUDOR INVESTMENT CORP ET AL 15,817 15,817 0.00 36 40 11.11
2017-10-20 N-Q Strategic Funds, Inc. (see advisory)
2018-02-27 N-Q Blackstone Alternative Investment Funds (see advisory)
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-04-19 13F-HR Factorial Partners, Llc 144,255 360,637
2017-11-13 13F-HR CITIGROUP INC 723 0 -100.00 3 0 -100.00
2017-11-01 N-Q Heartland Group Inc (see advisory)
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 0 6 0 1
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 131,812 131,812 0.00 300 330 10.00
2017-11-06 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 10,794 0 -100.00 50 0 -100.00
2017-11-08 13F-HR FULLER & THALER ASSET MANAGEMENT, INC. 129,300 0 -100.00 595 0 -100.00
2018-02-14 13F-HR TWO SIGMA INVESTMENTS LLC 42,863 29,129 -32.04 98 73 -25.51
2017-11-29 N-Q Investment Managers Series Trust (see advisory)
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 3 3 0.00 7 8 14.29
2018-02-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 70,894 0 -100.00 161 0 -100.00
2017-11-13 13F-HR KENNEDY CAPITAL MANAGEMENT, INC. 785,567 0 -100.00 3,614 0 -100.00
2018-02-14 13F-HR ROYAL BANK OF CANADA 1,509 1,509 0.00 3 4 33.33
2018-02-09 13F-HR EAGLE BOSTON INVESTMENT MANAGEMENT INC 548,279 571,399 4.22 1,288 1,428 10.87
2018-02-13 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 26,294 0 -100.00 60 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 0 14,663 0 37
2018-03-12 SC 13D/A Philotimo Fund, LP 811,305 549,365 -32.29
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 83,916 83,916 0.00 190 209 10.00
2018-01-23 13F-HR RICE HALL JAMES & ASSOCIATES, LLC 211,813 205,932 -2.78 482 515 6.85
2018-01-23 13F-HR STRS OHIO 200,000 200,000 0.00 455 500 9.89
2018-02-14 13F-HR MACQUARIE GROUP LTD 77,528 12,667 -83.66 176 32 -81.82
2018-02-09 13F-HR SYNOVUS FINANCIAL CORP 122,461 342,511 179.69 285 852 198.95
2018-02-09 13F-HR Virtu Financial LLC 14,937 37
2018-02-02 13F-HR HEARTLAND ADVISORS INC 114,669 0 -100.00 261 0 -100.00
2018-02-14 13F-HR TWO SIGMA ADVISERS, LP 52,800 52,400 -0.76 120 131 9.17
2018-02-14 13F-HR NORTHERN TRUST CORP 52,799 55,823 5.73 120 139 15.83
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,675 12,200 -10.79 70 31 -55.71
2018-02-14 13F-HR VANGUARD GROUP INC 326,006 326,006 0.00 742 815 9.84
2017-10-23 N-Q Blackrock Master Llc (see advisory)
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 14,900 14,900 0.00 34 37 8.82
2018-02-14 13F-HR Summit Trail Advisors, Llc 8,696 26
2018-02-02 13F-HR Alambic Investment Management, L.P. 18,802 0 -100.00 43 0 -100.00
2017-11-14 13F-HR I.G. INVESTMENT MANAGEMENT, LTD. 0 43,208 0 99

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( BBRG / Bravo Brio Restaurant Group, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 10567B109